(Q24289181)

English

Multiplicities in cancer research: ubiquitous and necessary evils

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Multiplicities in cancer research: ubiquitous and necessary evils (English)

0 references

author name string

Donald Berry

series ordinal

1

0 references

language of work or name

English

0 references

publication date

8 August 2012

0 references

published in

Journal of the National Cancer Institute

0 references

volume

104

0 references

issue

15

0 references

page(s)

1124-32

0 references

cites work

Why most published research findings are false

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

19 March 2017

Drug development: Raise standards for preclinical cancer research

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

19 March 2017

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

19 March 2017

No adjustments are needed for multiple comparisons

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

19 March 2017

Estimation of the multiple testing burden for genomewide association studies of nearly all common variants

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

7 April 2017

Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

27 September 2017

P = nothing, or why we should not teach healthcare students about statistics.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

29 November 2018

The difficult and ubiquitous problems of multiplicities.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

29 November 2018

Building and validating a prognostic index for biomarker studies.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

29 November 2018

HER2 and responsiveness of breast cancer to adjuvant chemotherapy.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

29 November 2018

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4614276

retrieved

29 November 2018

HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22859849

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22859849

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22859849

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/22859849

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

PubMed publication ID

22859849

0 references

ResearchGate publication ID

230616731

0 references

(Q24289181)

Multiplicities in cancer research: ubiquitous and necessary evils

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)